Catatonic Syndrome: Importance of Detection and Treatment with Lorazepam

References

• Cohen D. Toward a valid nosography and psychopathology of catatonia in children and adolescents. Int Rev Neurobiol. 2006; 72:131–147.
   Google Scholar
• Neumarker K. Classification matters for catatonia and autism in children. Rev Neurobiol. 2006;72:3–19.
   Google Scholar
• Taylor M, Fink M. Catatonia in psychiatric classification: a home of its own. Am J Psychiatry. 2003;160:1233–1241.
   PubMed Web of Science ®Google Scholar
• Fink M, Taylor MA. Catatonia: subtype or syndrome in DSM? Am J Psychiatry. 2006;163:1875–1876.
   Google Scholar
• Chagnon Y. Shared susceptibility region on chromosome 15 between autism and catatonia. Int Rev Neurobiol. 2006; 72:165–178.
   Google Scholar
• Plana M, Blanch J, Romero S, Serra M, Gasto C. Toxic catatonia secondary to azithromycin. J Clin Psychiatry. 2006;67:492–493.
   Google Scholar
• Chouinard M, Nguyen D, Clement J, Bruneau M. Catatonia induced by levetiracetam. Epilepsy Behav. 2006;8:303–307.
   PubMed Web of Science ®Google Scholar
• Elia J, Dell M, Friedman D, Zimmerman R, Balamuth N, Ahmed A, Pati S. PANDAS with catatonia: a case report. Therapeutic response to lorazepam and plasmapheresis. J Am Acad Child Ado-lesc Psychiatry. 2005;44:1145–1150.
   Google Scholar
• Dhossche D, Carroll B, Carroll T. Is there a common neuronal basis for autism and catatonia? Int Rev Neurobiol. 2006; 72:151–164.
   Google Scholar
• Shah A, Wing L. Psychological approaches to chronic catatonia-like deterioration in autism spectrum disorders. Int Rev Neurobiol. 2006;72:245–264.
   Google Scholar
• McDaniel W, Spiegel D, Sahota A. Topiramate effect in catato-nia: a case series. J Neuropsychiatry Clin Neurosci. 2006; 18:234–238.
   PubMed Web of Science ®Google Scholar
• Tan Q, Wang W, Wang H, Zhang R, Guo L, Zhang Y. Treatment of catatonic stupor with combination of modified electroconvul-sive treatment and olanzapine: a case report. Clin Neuropharma-col. 2006;29:154–156.
   Google Scholar
• Carpenter S, Hatchet A, Fuller M. Catatonic schizophrenia and the use of memantine. Ann Pharmacother. 2006;40:344–346.
   PubMed Web of Science ®Google Scholar
• Taylor M, Abrams R. Catatonia: prevalence and importance in the manic phase of manic depressive illness. Arch Gen Psychiatry. 1977;34:1223–1225.
   PubMed Web of Science ®Google Scholar
• Hung Y, Huang T. Lorazepam and diazepam rapidly relieve cata-tonic features in major depression. Clin Neuropharmacol. 2006; 29:144–147.
   Google Scholar
• Ungvari GA, Rankin JF. Lorazepam monotherapy for catatonic stupor. J Clin Psychopharmacology. 1989;9(2) :154.
   Google Scholar
• Bush G, Fink M, Petrides G, Dowling F, Francis A. Catatonia II. Treatment with lorazepam and electroconvulsive therapy. Acta Psychiatrica Scand. 1996;93:137–143.
   PubMed Web of Science ®Google Scholar
• Fricchione GL, Cassem NH, Hooberman D. Intravenous lorazepam in neuroleptic-induced catatonia. J Clin Psychophar-macology. 1983;3:338–342.
   Google Scholar
• Chandrasekharan R, Hani Payee, Raju GVL. Catatonic syndrome: treatment response to lorazepam. Indian J Psychiatry. 1999; 41(1):49–53.
   Google Scholar
• Chalasani P. Healy D, Morriss R. Presentation and frequency of catatonia in new admissions to two acute psychiatric admission units in India and Wales. Psychol Med. 2005;35:1667–167.
   Google Scholar
• Bush G, Fink M, Petrides G, Dowling F, Francis A. Catatonia I. Rating scale and standardized examination. Acta Psychiatrica Scand. 1996;93:129–136.
   PubMed Web of Science ®Google Scholar
• Rosebush PI, Hildebrand AM, Furlong BG, Mazurek MF. Cata-tonic syndrome in a general psychiatric inpatient population: fre-quency, clinical presentation, and response to lorazepam. J Clin Psychiatry. 1990;51(9) :357–362.
   PubMedGoogle Scholar
• van der Heijden F, Tuinier S, Arts N, Hoogendoorn MLC, Kahn RS, Verhoeven WMA. Catatonia: disappeared or underdiag-nosed? Psychopathology. 2005;38:3-8.
   Google Scholar
• Carpenter WT Jr, Bartko JJ, Carpenter CL, Strauss JS. Another view of schizophrenic subtypes: a report from the International Pilot Study of Schizophrenia. Arch Gen Psychiatry. 1976; 33:508–516.
   Google Scholar
• Rogers D. The motor disorders of severe psychiatric illness: a conflict of paradigm. Br J Psychiatry. 1985;147:221–232.
   Google Scholar
• Starkstein S, Petracca G, Teson A, Chemerinski E, Merello M, Migliorelli R, Leiguarda R. Catatonia in depression. J Neurol Neurosurg Psychiatry. 1996;60:326–332.
   PubMed Web of Science ®Google Scholar
• Ungvari GS, Leung CM, Wong MK, Lau J. Benzodiazepines in the treatment of catatonic syndrome. Acta Psychiatrica Scand. 1994;89:285–288.
   PubMedGoogle Scholar
• Hung Y, Yang P, Huang T. Clozapine in schizophrenia patients with recurrent catatonia: report of two cases. Psychiatry Clin Neu-rosci. 2006;60:256–258.
   Google Scholar
• Dursun S, Hallak J, Haddad P. Leahy A, Byrne A, Strickland PL, Anderson IM, Zuardi AW, Deakin JFW. Clozapine monotherapy for catatonic schizophrenia: should clozapine be the treatment of choice, with catatonia rather than psychosis as the main therapeu-tic index? J Psychopharmacol. 2005;19:432–433.
   Google Scholar
• Kritzinger P. Jordaan G. Catatonia: an open prospective series with carbamazepine. Int J Neuropsychopharmacol. 2001; 4:251–257.
   Google Scholar
• Dewan M, Koss M. The clinical impact of reported variance in potency of antipsychotic agents. Acta Psychiatrica Scandinavia. 1995;91:229–232.
   PubMedGoogle Scholar
• Salzman C. Use of benzodiazepines to control disruptive behavior in inpatients. J Clinical Psychiatry. 1988;49(Suppl 12):13–15.
   Google Scholar